Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The dose will be increased.
B The medication will be stopped.
C The dose will be decreased.
D The dose will be unchanged.
Question #2
A Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
B Not a candidate for fondaparinux based on an insufficient creatinine clearance
C Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
D Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
Question #3
A Too low
B Too high
C Within normal limits
D Inadequate to evaluate treatment
Question #4
A Within normal limits
B Inadequate to evaluate treatment
C Significantly decreased
D Significantly elevated
Question #5
A Administer prescribed vitamin K if bruising is observed.
B Assess for dysrhythmias.
C Stop the medication if the systolic blood pressure drops below 110 mm Hg.
D Monitor liver enzymes.
Question #6
A Administering the medication intramuscularly in the vastus lateralis
B Administering the medication when convenient
C Checking if the patient’s prescription contains enoxaparin
D Massaging the site after the injection
Question #7
A “I do not take aspirin for pain relief.”
B “I refrain from drinking coffee and citrus fruit juices daily.”
C “I eat 1 cup of green leafy vegetables daily.”
D “I take ginkgo supplements for memory enhancement.”
Question #8
A “I’ve been on prolonged bed rest.”
B “I get up and walk around at least once an hour.”
C “I never sit with my legs crossed at the knees.”
D “I avoid tight-fitting stockings or leggings.”
Question #9
A Tranexamic acid
B Aminocaproic acid
C Alteplase
D Phytonadione
Question #10
A Cimetidine
B Carbamazepine
C Barbiturate
D Cholestyramine
Question #11
A Heart rate, Hemoglobin, Blood pressure
B Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
C Platelet count, Heart rate, Blood pressure
D Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
Question #12
A “I will take the medication with food.”
B “I will store the bottle in a dry place.”
C “I will use the medication within 60 days after it is opened.”
D “I will place the pills in an organizer for easy use.”
Question #13
A Platelet count of 80,000/mm3
B Creatinine clearance of 25 mL/min
C Loss of 10 pounds
D Diagnosis of diabetes mellitus
Question #14
A The dosage of the warfarin will be decreased by half.
B The dosage of the warfarin will be increased by half.
C The dosage of the amiodarone will be decreased by half.
D The dosage of the amiodarone will be increased by half.
Question #15
A Instruct the patient to notify the nurse if he or she begins to experience discomfort.
B Monitor the patient for decreased action of the anticoagulant.
C Monitor the patient for increased action of the anticoagulant.
D Continue to administer cimetidine with each dose of warfarin.
Question #16
A Gastrointestinal bleed
B Peptic ulcer disease
C Local thrombosis from a peripheral intravenous line
D Severe chest pain for the past 2 hours
Question #17
A Increase the dose of heparin.
B Notify the health care provider immediately.
C Monitor the patient and check the therapeutic range.
D Stop the medication.
Question #18
A Cannot be interpreted without knowing the prothrombin time and international normalized ratio
B Within the expected target therapeutic level of anticoagulation
C Outside the expected target therapeutic level of anticoagulation; it is too high
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #19
A Hemoglobin level: 11 g/dL
B Prothrombin time: 13 sec
C Platelet count: 100,000/mm3
D Leukocyte count: 3000 cells/mm3
Question #20
A Atrial fibrillation, History of myocardial infarction
B Chronic obstructive pulmonary disease, Atrial fibrillation
C History of myocardial infarction, Chronic obstructive pulmonary disease
D Peptic ulcer disease, Chronic kidney disease
Question #21
A Platelet count of 95,000/mm3
B Activated partial thromboplastin time (aPTT) of 37 seconds
C International normalized ratio (INR) of 1
D Potassium level of 3.5 mEq/L
Question #22
A The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
B Outside the expected target therapeutic level of anticoagulation; it is too low
C Within the expected target therapeutic level of anticoagulation
D Outside the expected target therapeutic level of anticoagulation; it is too high
Question #23
A “Discard the drug within 21 days of opening the original container.”
B “Store the drug with the desiccant-drying agent in the packing cap.”
C “Remove from the original package and place in aluminum foil.”
D “Refrigerate and keep away from direct sunlight.”
Question #24
A Ketoconazole
B Amiodarone
C Enoxaparin
D Furosemide
Question #25
A Have protamine sulfate readily available at all times.
B Monitor the patient’s laboratory values correctly.
C Teach the patient about dietary restrictions while on the medication.
D Ensure that a loading dose was initially administered when beginning
Question #26
A Administer vitamin K1 (phytonadione) IV.
B Stop the intravenous (IV) drip.
C Wait for the INR to decrease.
D Administer protamine sulfate IV.
Question #27
A Reversal of damage from the infarction
B Dissolution of the clot that caused the heart attack
C Prevention of new clots from forming
D A quick decrease in pain
Question #28
A “I should take oral contraceptives during the therapy.”
B “I should follow a low-cholesterol diet during the therapy.”
C “I should not use any acetaminophen during the therapy.”
D “I should refrain from eating broccoli during the therapy.”
Question #29
A “I should use a soft toothbrush for dental hygiene.”
B “I should keep taking ibuprofen for my arthritis.”
C “I should decrease the dose if I start bruising easily.”
D “I will double my dose if I forget to take it the day before.”
Question #30
A “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
B “There is no real difference; dalteparin is interchangeable with regular heparin.”
C “The only difference is that regular heparin dosing is based on the patient’s weight.”
D “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
Question #31
A Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
B Rub the administration site after injecting.
C Utilize the Z-track method to inject the medication.
D Administer the medication into subcutaneous tissue of the abdomen.
Question #32
A “I will increase dark green leafy vegetables in my diet.”
B “I will contact my health care provider if I develop excessive bruising.”
C “I will avoid contact sports.”
D “I will take my medication at the same time each day.”
Question #33
A Protamine sulfate
B Vitamin E
C Vitamin K
D Calcium gluconate
Question #34
A Vitamin K daily
B Warfarin daily
C Aspirin daily (i.e., 81 mg)
D Recombinant factors
Question #35
A Transient ischemic attack
B Acute unstable angina
C Vitamin K deficiency
D Peripheral vascular disease
Question #36
A Warfarin orally
B Dabigatran orally
C Enoxaparin intramuscularly
D Heparin subcutaneously
Question #37
A Over-the-counter medications
B Urine culture
C Ingestion of acetaminophen
D Platelet level
Question #38
A September 15
B October 1
C July 31
D August 29
Question #39
A Chest pain
B Itching
C Nausea
D Edema
Question #40
A International normalized ratio (INR) of 1.0
B Blood urea nitrogen (BUN) level of 12 mg/dL
C Activated partial thromboplastin time (aPTT) of 120 seconds
D Platelet count of 150,000 mm3
Question #41
A Fasting blood glucose level of 95 mg/dL
B Creatinine clearance value of 40 mL/min
C Platelet count of 75,000 cell/μL
D Hemoglobin level of 16.5 g/dL
Question #42
A Factor Xa
B Antithrombin III
C Vitamin K
D Thrombin
Question #43
A Tranexamic acid
B Alteplase
C Desmopressin
D Aminocaproic acid
Question #44
A Thrombolytic
B Antiplatelet
C Antifibrinolytic
D Anticoagulant
Question #45
A Cardiomyopathy
B Coronary artery disease
C Heart failure
D Acute myocardial infarction
Question #46
A Aspirin
B Cilostazol
C Pentoxifylline
D Dipyridamole
Question #47
A Dabigatran
B Fondaparinux
C Enoxaparin
D Argatroban
Question #48
A Direct thrombin inhibitors
B Heparins
C Selective factor Xa inhibitors
D Warfarin
Question #49
A Anticoagulants prevent clots from forming.
B Anticoagulants dissolve clots.
C Anticoagulants alter platelet function.
D Anticoagulants interfere with drug metabolism.
Question #50
A Thrombolytic
B Anticoagulant
C Antifibrinolytic
D Antiplatelet
Question #51
A Medication reaction
B Embolus to the lungs
C Fatigue from walking with pain
D Anxiety
Question #52
A Infusing 50 mL of warfarin sodium
B Administering vitamin K1
C Increasing the dose of enoxaparin
D Administering protamine sulfate
Question #53
A Calcium
B Potassium
C Vitamin K
D Aspirin